0001144204-11-025461.txt : 20110502 0001144204-11-025461.hdr.sgml : 20110502 20110502163247 ACCESSION NUMBER: 0001144204-11-025461 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110502 FILED AS OF DATE: 20110502 DATE AS OF CHANGE: 20110502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PETERSON PETER M CENTRAL INDEX KEY: 0001260044 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 333-72097 FILM NUMBER: 11801149 MAIL ADDRESS: STREET 1: 204 NW PLATTE VALLEY DRIVE CITY: RIVERSIDE STATE: MO ZIP: 64150 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201 STREET 2: SUITE 201 CITY: NAPLES STATE: FL ZIP: 34108 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 1726 MEDICAL BOULEVARD, SUITE 201 STREET 2: SUITE 201 CITY: NAPLES STATE: FL ZIP: 34108 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 3 1 form319158_050211163122-.xml X0203 3 2011-05-02 0 0001077183 NEOGENOMICS INC NGNM.OB 0001260044 PETERSON PETER M C/O NEOGENOMICS, INC. 12701 COMMONWEALTH DRIVE, SUITE 9 FORT MYERS FL US 33913 1 0 1 0 Common Stock 8038123 I By Aspen Select Healthcare, LP Common Stock 129427 I By Aspen Opportunity Fund, LP Common Stock 24000 D Warrant (Right to Buy) 1.5 2007-06-07 2012-06-07 Common Stock 100000 D Warrant (Right to Buy) 0.75 2009-02-09 2014-02-09 Common Stock 83333 I By Gulf Pointe Capital, LLC Aspen Select Healthcare, LP is a private investment fund. Medical Venture Partners, LLC is the sole general partner of Aspen Select Healthcare, LP, and Mr. Peterson is a Managing Member of Medical Venture Partners, LLC. Mr. Peterson disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. An investment entity controlled by Peter Peterson. Mr. Peterson disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. On April 27, 2011 the Board of Directors approved and granted a restricted stock award of 24,000 shares of NeoGenomics common stock. The terms of the award call for 2,000 shares to vest on the last day of the next 12 quarters starting on June 30, 2011 as long as Mr. Peterson remains a Director of the Company. /s/ Peter M. Peterson 2011-05-02